LogicBio

Lexington, United States Founded: 2013 • Age: 13 yrs Acquired By Alexion
Viral vectors are developed for genetic and infectious disease treatments.
Request Access

About LogicBio

LogicBio is a company based in Lexington (United States) founded in 2013 was acquired by Alexion in October 2022.. LogicBio has raised $49 million across 3 funding rounds from investors including Alexion, Orbimed and Edmond de Rothschild. LogicBio operates in a competitive market with competitors including Spark Therapeutics, AskBio, Unity Biotechnology, Editas Medicine and GBT, among others.

  • Headquarter Lexington, United States
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Logicbio Therapeutics, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $49 M (USD)

    in 3 rounds

  • Latest Funding Round
    $20 M (USD), Debt – Conventional

    Jul 02, 2019

  • Investors
    Alexion

    & 7 more

  • Employee Count
    Employee Count
  • Acquired by
    Alexion

    (Oct 03, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of LogicBio
Headcount 1000-5000
Employee Profiles 162
Board Members and Advisors 7
Employee Profiles
People
Saurabh Shende
Data Consultant - Patient Services
People
Brian Gosper
Associate Director, Sales Operations, Pnh, Hematology And Nephrology Business Unit
People
Cole Allen
Director, US Strategic Account Lead
People
Kevin Siska
Sr. Regional Sales Director, Nf1 PN

Unlock access to complete

Funding Insights of LogicBio

LogicBio has successfully raised a total of $49M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $20 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Debt – Conventional — $20.0M
  • First Round

    (20 Jan 2016)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2019 Amount Debt – Conventional - LogicBio Valuation

investors

Jul, 2017 Amount Series B - LogicBio Valuation Arix Bioscience
Jan, 2016 Amount Series A - LogicBio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in LogicBio

LogicBio has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Alexion, Orbimed and Edmond de Rothschild. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture debt firm focused on the life sciences sector
Founded Year Domain Location
Structured debt is provided to life sciences and technology firms.
Founded Year Domain Location
Investments in biotech startups are made by Arix Bioscience.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by LogicBio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - LogicBio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Logicbio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of LogicBio

LogicBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Spark Therapeutics, AskBio, Unity Biotechnology, Editas Medicine and GBT, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Gene therapies for rare diseases including retinal dystrophies are developed.
domain founded_year HQ Location
Gene and protein therapies are developed for treating various diseases.
domain founded_year HQ Location
Therapeutics for aging diseases are developed by targeting senescent cells.
domain founded_year HQ Location
Therapeutics for rare genetic diseases are developed using CRISPR technology.
domain founded_year HQ Location
Small molecules are developed for sickle cell disease treatment.
domain founded_year HQ Location
Gene therapies for rare liver and eye diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Logicbio

Frequently Asked Questions about LogicBio

When was LogicBio founded?

LogicBio was founded in 2013 and raised its 1st funding round 3 years after it was founded.

Where is LogicBio located?

LogicBio is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

Who is the current CEO of LogicBio?

Frederic Chereau is the current CEO of LogicBio.

Is LogicBio a funded company?

LogicBio is a funded company, having raised a total of $49M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Jan 20, 2016.

What does LogicBio do?

LogicBio Therapeutics was founded in 2013 and is headquartered in Lexington, United States. Operations focus on the biotechnology sector, where gene therapy platforms based on non-pathogenic Adeno-Associated Viral (AAV) vectors are developed. These vectors target genetic conditions such as hemophilia and methylmalonic acidemia (MMA), along with infectious diseases including HIVAIDS, for use in both pediatric and adult patients.

Who are the top competitors of LogicBio?

LogicBio's top competitors include Spark Therapeutics, Generation Bio and GBT.

Who are LogicBio's investors?

LogicBio has 8 investors. Key investors include Alexion, Orbimed, Edmond de Rothschild, Oxford Finance, and Horizon Tech Finance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available